Breaking News
The car and truck makers need the products they sold you decades ago to stop working
Muslims Hate Dogs - so the BBC now pushing anti dog propaganda. Defund the BBC.
Trump Threatens To 'Blow Up' Iran's Desalination Plants
US Launches 48th Airstrike in Somalia of the Year
Top Tech News
The Secret Spy Tech Inside Every Credit Card
Red light therapy boosts retinal health in early macular degeneration
Hydrogen-powered business jet edges closer to certification
This House Is 10 Feet Underground and Costs $0 to Cool. Why Is It Banned in 30 States?
Cold Tolerant Lithium Battery?? Without Heaters!? Ecoworthy Cubix 100 Pro!
DLR Tests Hydrogen Fuel for Aviation at -253°C
Watch: China Claims Cyborg Breakthrough To Build An "Army Of Centaurs"
Instant, real-time video AI is now upon us, for better and worse
We Build and Test Microwave Blocking Panels - Invisible to Radar
Man Successfully Designs mRNA Vaccine To Treat His Dog's Cancer
New blood, computer brains and frozen heads: How billionaires 'will live forever'
Over the past year, the gap between the super-rich and the rest of us has grown wider than ever before.
But the difference between ordinary people and billionaires might be more than just money. Some high net worth individuals have been looking into extending their lives far beyond the 70 or 80 years most of us might hope for.
Peter Thiel, for example, the billionaire co-founder of PayPal, has invested in a number medical research start-ups looking extending life expectancy though his Breakout Labs fund.
One of the companies longevity obsessive Thiel has bankrolled is Ambrosia.
Ambrosia is one of three outfits looking at experimental "vampire" blood transfusions that put the blood of young people into the lens of oldies.
According to commercial finance experts ABC Finance, the cost of the trials currently ranges from £6,000 to about £215,000.